Pea (Pisum sativum) allergy in children: Pis s 1 is an immunodominant major pea allergen and presents IgE binding sites with potential diagnostic value
Open Access
- 1 May 2020
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 50 (5), 625-635
- https://doi.org/10.1111/cea.13590
Abstract
Background Food allergy to pea (Pisum sativum) has been rarely studied in children at the clinical and molecular levels. Objective To elucidate the allergenic relevance and diagnostic value of pea 7S globulin Pis s 1, nsLTP, and 2S albumins PA1 and PA2 in children. Methods Children with pea-specific IgE >= 0.35 kU(A)/L and clinical evidence of pea allergy or tolerance were included in the study. IgE binding against pea total protein extract, recombinant (r) rPis s 1, rPA1, rPA2, and natural nsLTP was analysed using IgE immunoblot/inhibition. Mediator release potency was investigated in passively sensitized rat basophil leukaemia (RBL) 2H3-cells. IgE binding to synthetic overlapping peptides of Pis s 1 was detected on multipeptide microarrays. Results 19 pea-sensitized children were included, 14 with doctors' diagnosed allergy and 5 with tolerance to pea (median age 3.5 and 4.5 years, respectively). 11/14 (78%) pea-allergic and 1/5 (20%) tolerant children were sensitized to Pis s 1. Under the reducing conditions of immunoblot analysis, IgE binding to rPA1 was negligible, sensitization to rPA2 and nsLTP undetectable. Compared to pea total protein extract, rPis s 1 displayed on average 58% IgE binding capacity and a 20-fold higher mediator release potency. Selected Pis s 1-related peptides displayed IgE binding in pea-allergic but not in pea-tolerant children. Conclusions and Clinical Relevance In this study group, Pis s 1 is a major immunodominant allergen in pea-allergic children. Evidence for sensitization to nsLTP and 2S albumins was low but requires further verification with regard to conformational epitopes. Recombinant Pis s 1 and related peptides which were exclusively recognized by pea-allergic children may improve in vitro diagnosis of pea allergy once verified in prospective studies with larger study groups.This publication has 36 references indexed in Scilit:
- Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology–European Academy of Allergy and Clinical Immunology PRACTALL consensus reportJournal of Allergy and Clinical Immunology, 2012
- Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitorsClinical & Experimental Allergy, 2009
- High level expression, purification and physico- and immunochemical characterisation of recombinant Pen a 1: A major allergen of shrimpMolecular Nutrition & Food Research, 2008
- Strategy for allergenicity assessment of ?natural novel foods?: clinical and molecular investigation of exotic vegetables (water spinach, hyacinth bean and Ethiopian eggplant)Allergy, 2007
- Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy?Clinical & Experimental Allergy, 2006
- Genetic Variation in Pea Seed Globulin CompositionJournal of Agricultural and Food Chemistry, 2005
- Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human systemAllergy, 2005
- Vicilin and convicilin are potential major allergens from peaClinical & Experimental Allergy, 2004
- The roles of the N‐linked glycans and extension regions of soybean β‐conglycinin in folding, assembly and structural featuresJBIC Journal of Biological Inorganic Chemistry, 1998
- The isolation of allergens from the green peaJournal of Allergy and Clinical Immunology, 1975